- Last 2 years crossed 1.5C global warming limit: EU monitor
- Asian markets drift lower as US jobs data looms
- Sabalenka has 'target on her back' in pursuit of Australian Open 'history'
- Croatia's populist president tipped for re-election
- Veteran Monfils powers past teenager to reach 35th final
- Japan 'poop master' gives back to nature
- UN watchdog says Australia violated asylum seekers' rights
- Murray braced for Djokovic ire in coaching debut at Australian Open
- At CES, AI-powered garbage trucks reduce battery fire risk
- S. Korea presidential security chief urges 'no bloodshed' in Yoon arrest
- Combustible Kyrgios says tennis 'a bit mundane' without him
- US Supreme Court to hear TikTok ban case
- Los Angeles Rams playoff game moved to Arizona over fires: NFL
- Survivors patrol as looters prey on fire-wrecked Los Angeles
- US 'Pizzagate' conspiracy theory gunman killed by police: media
- ATP chief insists Sinner doping case 'run by the book'
- Musk promotes German far-right leader in latest European intervention
- Inter Miami's Mascherano cools Neymar talk
- Danish PM reaches out to Trump over Greenland remarks
- Everton advance in FA Cup after Dyche dismissal
- Maria Corina Machado: the face and fire of Venezuela's opposition
- Real Madrid defeat Mallorca to reach Clasico Spanish Super Cup final
- Jackson seeks deep Ravens run as NFL playoffs begin
- Returning Evenepoel expects to be 'in very good shape' for Tour de France
- Djokovic claims he was 'poisoned' before 2022 Australian Open deportation
- NBA postpones Lakers-Hornets game due to LA-area wildfires
- Harmison wants England captain Buttler to be spared Afghanistan boycott decision
- 'We're not afraid': Venezuelans defy repression to challenge Maduro's rule
- Paris Hilton among celebrities to lose homes in LA fires
- US Fed's December rate cut was 'final' step to recalibrate policy: official
- Airbus boosts plane deliveries in 2024
- Rising star Diallo signs new Man Utd contract
- Quintero edges Dakar stage after Al Attiyah penalised
- Ubisoft reviews restructuring options, postpones new Assassin's Creed
- Jimmy Carter briefly unites US as presidents attend funeral
- E-Power hits the slopes: new wave of snow sports emerges
- Video game play gets frisky at CES gadget gala
- London Van Gogh show to open all night to meet demand
- Leverkusen chase 'perfection' as Bayern hunt resumes
- What do we know about latest Gaza talks?
- Lamborghini sets new sales record amidst hybrid push
- Struggling Everton sack manager Dyche
- Bochum awarded win over Union Berlin after keeper hit by lighter
- Chad says bid to storm into presidential palace foiled, 20 dead
- 'Venezuela will be free': anti-Maduro protests roil Caracas
- Macron welcomes 'crucial election' of new Lebanon president
- France charges founder of adult website linked to mass rape trial: prosecutors
- Jimmy Carter unites US as presidents attend state funeral
- Shocked LA residents survey fire damage, brace for more
- Chinese foreign minister pledges military aid for Africa
New US strategy to make monkeypox vaccine go further
US health authorities on Tuesday authorized a new procedure for injecting the monkeypox vaccine that should make it possible to inoculate more people with the same amount of the drug, at a time when doses are running short in the country.
The Food and Drug Administration also authorized giving the vaccine to people under the age of 18 who are considered to be at high risk of infection.
For those over 18, health workers will now be able to administer the vaccine differently, via an intradermal injection -- that is, between the upper layers of the skin -- and not with a deeper, subcutaneous injection.
The new method will "increase the total number of doses available for use by up to five-fold," the FDA said in a statement.
Two injections, four weeks apart, will still be necessary.
The FDA said it was drawing on data from a 2015 clinical trial that showed a similar immune response in people given a subcutaneous injection compared to those given a fifth of the dose via an intradermal shot.
At present, some 620,000 doses of the vaccine -- manufactured by Bavarian Nordic, and marketed under the name Jynneos in the United States -- have been distributed across the country.
Another 440,000 additional doses are still to be distributed, which could allow up to 2.2 million injections under the new strategy.
The government has also ordered an additional five million doses, which will start arriving from September and run through 2023, affording the potential to administer 25 million doses.
The decisions came after the FDA issued an emergency use authorization for the vaccine, a move that itself followed the declaration of a public health emergency last week.
For the authorization in minors, the FDA said it had reviewed safety data for the vaccine, as well as data for another vaccine given in children against smallpox.
"We feel very comfortable with the safety of the approach," said Peter Marks of the FDA at a press conference, noting a recent increase in the number of children who have potentially been exposed to infected people.
The United States has registered nearly 9,000 cases of monkeypox, a fifth of them in New York state. The vast majority of cases involve men who have had sex with men.
X.M.Francisco--PC